All undergraduate and graduate students must receive a booster and update their vaccination information in your
MyUHS portal by Monday, January 31, or 30 days after they become eligible. For answers to commonly asked questions about this vaccine requirement (e.g., booster eligibility, uploading proof of vaccination instructions, etc.), visit the University’s
COVID website.
At present, the University is accepting those vaccines authorized for emergency use by the Food and Drug Administration (FDA) as recommended by the CDC’s Advisory Committee on Immunization Practices (ACIP), as well as those authorized by the World Health Organization EUL. The following COVID vaccines are being accepted:
- FDA-Authorized: Pfizer (Comirnaty), Moderna (Spikevax), J&J (Janssen)
- WHO EUL-Authorized, including but not limited to: AstraZeneca/Oxford (SK-BIO, Covishield, Vaxzevria), Sinopharm (BBIBP-CorV), Sinovac (CoronaVac), Bharat Biotech (COVAXIN); please see WHO -- COVID19 Vaccine Tracker (trackvaccines.org) for the current and full list of WHO vaccines accepted by the University.
Students who are abroad and are unable to obtain an FDA or WHO EUL-authorized vaccine may receive an FDA-authorized vaccine when they arrive in the United States. If you are unsure whether you can receive an approved vaccine before returning to campus for the fall semester, please email myuhs@princeton.edu so that UHS can work with you to receive the vaccine once you arrive in Princeton.
For additional questions, please email covidvaccines@princeton.edu.